Conjugated linoleic acid (CLA) is formed from linoleic acid (LA; cis-9,cis-12-18 : 2) by intestinal bacteria. Different CLA isomers have different implications for human health. The aim of this study was to investigate LA metabolism and the CLA isomers formed in two individuals (V1 and V2) with different faecal metabolic characteristics, and to compare fatty acid metabolism with the microbial community composition. LA incubated with faecal samples was metabolized at similar rates with both subjects, but the products were different. LA was metabolized extensively to stearic acid (SA; 18 : 0) in V1, with minor accumulation of CLA and more rapid accumulation of vaccenic acid (VA;. CLA accumulation at 4 h was almost tenfold higher with V2, and little SA was formed. At least 12 different isomers of CLA were produced from LA by the colonic bacteria from the two individuals. The predominant (.75 %) CLA isomer in V1 was rumenic acid (RA; cis-9,trans-11-18 : 2), whereas the concentrations of RA and trans-10,cis-12-18 : 2 were similar with V2. Propionate and butyrate proportions in short-chain fatty acids were higher in V1. A 16S rRNA clone library from V1 contained mainly Bacteroidetes (54 % of clones), whereas Firmicutes (66 % of clones) predominated in V2. Both samples were devoid of bacteria related to Clostridium proteoclasticum, the only gut bacterium known to metabolize VA to SA. Thus, the CLA formed in the intestine of different individuals may differ according to their resident microbiota, with possibly important implications with respect to gut health.
INTRODUCTIONConjugated linoleic acid (CLA) is a collective term used to describe positional and geometric isomers of linoleic acid (LA; cis-9,cis-12-18 : 2) containing a conjugated double bond. Evidence derived from studies in animal models and clinical trials indicates that CLA could have a number of beneficial effects on human health, including decreasing carcinogenesis and atherosclerosis, controlling body fat gain and enhancing the immune response as well as decreasing inflammation and other adverse effects typically associated with immune enhancement (McLeod et al., 2004;O'Shea et al., 2004;Wang & Jones, 2004;Lee et al., 2005;Tricon et al., 2005).The main source of CLA in man is ruminant-derived foods (Lawson et al., 2001). CLA may also be formed during metabolism of LA by intestinal bacteria, as demonstrated in rats (Eyssen & Parmentier, 1974;Chin et al., 1994;Ewaschuk et al., 2006) and man (Howard & Henderson, 1999;Devillard et al., 2006;Kamlage et al., 1999Kamlage et al., , 2000. CLA shows anti-inflammatory properties with colonocytes (Hontecillas et al., 2002;Bassaganya-Riera et al., 2004;Bassaganya-Riera & Hontecillas, 2006), and therefore could be therapeutic for inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. It has also been suggested that CLA inhibits the development of colorectal cancer Lampen et al., 2005;Lee et al., 2005; Beppu et al., 2006). Positional and geometric isomers of CLA may have different physiological ef...